First Trust Advisors LP Purchases 93,969 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

First Trust Advisors LP boosted its holdings in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 702.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 107,343 shares of the company's stock after purchasing an additional 93,969 shares during the quarter. First Trust Advisors LP owned about 0.19% of Astrana Health worth $3,385,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of ASTH. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Astrana Health in the 4th quarter worth about $40,000. KBC Group NV lifted its holdings in shares of Astrana Health by 108.4% in the fourth quarter. KBC Group NV now owns 2,530 shares of the company's stock valued at $80,000 after purchasing an additional 1,316 shares in the last quarter. US Bancorp DE boosted its position in shares of Astrana Health by 3,880.0% during the fourth quarter. US Bancorp DE now owns 4,776 shares of the company's stock valued at $151,000 after buying an additional 4,656 shares during the last quarter. Pictet Asset Management Holding SA grew its holdings in Astrana Health by 21.9% during the fourth quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company's stock worth $223,000 after buying an additional 1,273 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its position in Astrana Health by 19.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after buying an additional 1,184 shares during the last quarter. Institutional investors and hedge funds own 52.77% of the company's stock.

Astrana Health Price Performance

Shares of ASTH traded up $0.10 during mid-day trading on Wednesday, reaching $32.14. 296,391 shares of the stock traded hands, compared to its average volume of 279,685. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The company has a market cap of $1.80 billion, a price-to-earnings ratio of 24.72, a price-to-earnings-growth ratio of 1.37 and a beta of 1.00. The firm has a fifty day moving average price of $30.57 and a 200 day moving average price of $36.81. Astrana Health, Inc. has a 1 year low of $23.12 and a 1 year high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $665.21 million for the quarter, compared to the consensus estimate of $617.24 million. As a group, equities research analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Truist Financial lowered their target price on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a report on Tuesday, March 18th. Stifel Nicolaus cut their target price on Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a research note on Thursday, February 20th. Barclays started coverage on Astrana Health in a report on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price target on the stock. Robert W. Baird reduced their price objective on Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. Finally, Bank of America cut their price target on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a report on Tuesday, March 4th. Three equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Astrana Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $53.29.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.